A detailed history of Financial Insights, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Insights, Inc. holds 2,072 shares of NVO stock, worth $217,684. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,072
Previous 2,212 6.33%
Holding current value
$217,684
Previous $315,000 21.9%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$119.07 - $145.42 $16,669 - $20,358
-140 Reduced 6.33%
2,072 $246,000
Q3 2023

Dec 06, 2023

BUY
$90.94 - $199.54 $201,159 - $441,382
2,212 New
2,212 $201,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $73,867 - $93,292
-875 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $59,202 - $74,165
875 New
875 $733,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Insights, Inc. Portfolio

Follow Financial Insights, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Insights, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Insights, Inc. with notifications on news.